Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recent progress in the "fibrinogen hypothesis"].

P Lefebvre1, Th Ledent, J Ducobu

  • 1Service de Cardiologie, C.H.U. Tivoli, U.L.B.

Revue Medicale De Bruxelles
|June 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Thyroid nodules: benign or malignant?].

Revue medicale de Bruxelles·2011
Same author

Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.

Atherosclerosis·2011
Same author

[Pedagogy and clinical medicine].

Revue medicale de Bruxelles·2010
Same author

[New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].

Revue medicale de Bruxelles·2010
Same author

[Place of fibrates for the treatment of patients with atherogenic dyslipidemia].

Revue medicale de Liege·2009
Same author

Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients.

Atherosclerosis·2009
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

High plasma fibrinogen levels are a significant risk factor for arterial diseases, contributing to both thrombotic events and the development of atherosclerotic plaques. Its role in cardiovascular diseases, vasculopathies, and diabetes is complex and influenced by treatments like statins.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Epidemiology

Context:

  • Plasma fibrinogen is recognized as an independent risk factor for major arterial diseases, including coronary, cerebral, and peripheral artery disease.
  • The established role of fibrinogen in cardiovascular disease (CVD) involves promoting thrombotic complications in advanced atherothrombotic conditions.
  • Emerging evidence suggests fibrinogen actively participates in the initiation and progression of atheromatous plaque formation.

Purpose:

  • To explore the multifaceted role of fibrinogen in the pathogenesis of cardiovascular diseases.
  • To discuss the relationship between fibrinogen levels and ischemic cardiopathies, other vasculopathies, and diabetes mellitus.
  • To review the controversial effects of statin therapy on plasma fibrinogen levels.

Summary:

Related Experiment Videos

  • Clinical and epidemiological studies confirm elevated plasma fibrinogen as an independent risk factor for coronary, cerebral, and peripheral artery diseases.
  • Fibrinogen contributes to cardiovascular disease primarily through thrombotic complications but also actively participates in atheromatous plaque development.
  • The abstract examines links between fibrinogen, ischemic heart disease, other vascular conditions, and diabetes, alongside statins' debated impact on fibrinogen.

Impact:

  • Highlights fibrinogen's critical role beyond thrombosis in atherogenesis, offering new therapeutic targets.
  • Provides a comprehensive overview of fibrinogen's implications in vascular health and metabolic disorders.
  • Informs clinical practice regarding risk assessment and management strategies for patients with elevated fibrinogen.